Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Metastatic bone cancer causes severe pain that is primarily treated with opioids. A model of bone cancer pain in which the progression of cancer pain and bone destruction is tightly controlled was used to evaluate the effects of sustained morphine treatment. In cancer-treated mice, morphine enhanced, rather than diminished, spontaneous, and evoked pain; these effects were dose-dependent and naloxone-sensitive. SP and CGRP positive DRG cells did not differ between sarcoma or control mice, but were increased following morphine in both groups. Morphine increased ATF-3 expression only in DRG cells of sarcoma mice. Morphine did not alter tumor growth in vitro or tumor burden in vivo but accelerated sarcoma-induced bone destruction and doubled the incidence of spontaneous fracture in a dose- and naloxone-sensitive manner. Morphine increased osteoclast activity and upregulated IL-1 beta within the femurs of sarcoma-treated mice suggesting enhancement of sarcoma-induced osteolysis. These results indicate that sustained morphine increases pain, osteolysis, bone loss, and spontaneous fracture, as well as markers of neuronal damage in DRG cells and expression of pro-inflammatory cytokines. Morphine treatment may result in "add-on" mechanisms of pain beyond those engaged by sarcoma alone. While it is not known whether the present findings in this model of osteolytic sarcoma will generalize to other cancers or opioids, the data suggest a need for increased understanding of neurobiological consequences of prolonged opioid exposure which may allow improvements in the use of opiates in the effective management of cancer pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sommer, C., & Kress, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.007 · Cited by 815 · cited 1×
“IL-1b has also been implicated in peripheral sensitization after injury leading to inflammatory pain (Sommer and Kress, 2004).”
BackgroundLaulin, J. P., Célèrier, E., Larcher, A., Le Moal, M., & Simonnet, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00652-6 · Cited by 179 · cited 1×
“…including nonpeptidic agonists (e.g. morphine, oxymorphone, fentanyl) as well as peptides acting at l-opioid receptors (e.g. DAMGO) have been shown to produce hyperalgesia (Laulin et al., 1998, 1999; Vanderah et al., 2000; Gardell et al., 2002, 2006; Celerier et al., 2006; Pud et al., 2006).”
BackgroundLong-lasting increased pain sensitivity in rat following exposure to heroin for the first time
Laulin, J., Larcher, A., Célèrier, E., Moal, M. L., & Simonnet, G. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00083.x · Cited by 156 · cited 1×
“…including nonpeptidic agonists (e.g. morphine, oxymorphone, fentanyl) as well as peptides acting at l-opioid receptors (e.g. DAMGO) have been shown to produce hyperalgesia (Laulin et al., 1998, 1999; Vanderah et al., 2000; Gardell et al., 2002, 2006; Celerier et al., 2006; Pud et al., 2006).”
BackgroundOsteoclast formation and bone resorption are inhibited by megakaryocytes
Beeton, C. A., Bord, S., Ireland, D., & Compston, J. E. (2006) · Bone · doi:10.1016/j.bone.2006.06.004 · Cited by 61 · cited 2×
“To determine the number of osteoclasts, femurs were stained with Tartrate-resistant acid phosphatase (TRAP) kit (Sigma) as TRAP is commonly used as a marker of osteoclasts in bone as previously reported (Halleen et al., 1999; Takano et al., 2004, 2006; Beeton et al., 2006; Itoh et al., 2006; Ren et al., 2006; Wan et a…”
Method
Cited by
Postoperative opioid administration inhibits bone healing in an animal model
Chrastil, J., Sampson, C., Jones, K. B., & Higgins, T. F. (2013) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-013-3232-z · Cited by 74
“incidence of spontaneous fractures in sarcoma models [9]; however, the mechanism is still in question.”
BackgroundLiang, D., Shi, X., Qiao, Y., Angst, M. S., Yeomans, D. C., & Clark, J. D. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-7 · Cited by 71
Lee, M. C., Wanigasekera, V., & Tracey, I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.035 · Cited by 56
“…animals, relatively few animal studies demonstrate opioid-induced hyperalgesia in the presence of tissue injury (Celerier et al., 2006; Li et al., 2001; Liang et al., 2008), inflammation (Rivat et al., 2009) or cancer (King et al., 2007), suggesting that these pathological states are protective.”
BackgroundThe effect of opiates on bone formation and bone healing
Coluzzi, F., Scerpa, M. S., & Centanni, M. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00585-4 · Cited by 55
Analgesic effects of adenylyl cyclase inhibitor NB001 on bone cancer pain in a mouse model
Kang, W.-B., Yang, Q., Guo, Y.-Y., Wang, L., Wang, D.-S., Cheng, Q., Li, X.-M., Tang, J., Zhao, J.-N., Liu, G., et al. (2016) · Molecular Pain · doi:10.1177/1744806916652409 · Cited by 32
“An arthrotomy was performed as previous described.(5,19) A minimal skin incision was made and the patellar ligaments were cut, exposing the condyles 2 Molecular Pain”
BackgroundMethod
Metadata
- Authors
- King, T., Vardanyan, A., Majuta, L., Melemedjian, O., Nagle, R., Cress, A. E., Vanderah, T. W., Lai, J., & Porreca, F.
- Venue
- Pain
- Published
- 2007-11
- Volume
- 132
- Issue
- 1
- Pages
- 154-168
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1977289872
- Cited by
- 121
- References
- 4
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.